No standard guidelines for the management of MeN patients exist, and treatment strategies employed by health care providers vary widely. Based on clinical consensus from the most recent CENCAM meeting, no specific treatment exists beyond improving access to shade, hydration, and rest among individuals engaging in work that places them at risk for heat stress, as well as emphasizing access to clean air and water and avoidance of nephrotoxic substances. Care of advanced CKD due to MeN should likely be similar to that employed in advanced CKD of other causes. There are anecdotal reports of response to allopurinol (in response to elevated uric acid levels), corticosteroids (in response to acute tubulointerstitial nephritis on kidney biopsy), and use of angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), but the consensus is that there is insufficient evidence to support any of these therapies.
Mesoamerican nephropathy
IgA nephropathy
Malarial nephropathy
Balkan endemic nephropathy
Sickle cell nephropathy
Uddanam nephropathy
HIV-associated nephropathy
Analgesic nephropathy